Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pryce

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical and Experimental Immunology|July 17, 2020
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseasesD Baker, C A K Roberts, G Pryce, et al.
Clinical and Experimental Immunology|June 1, 1986
Characterization of monoclonal antibodies directed towards the microsomal/microvillar thyroid autoantigen recognized by Hashimoto autoantibodiesJ P Banga, R Mirakian, L Hammond, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2013
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitorsG Pryce, A Cabranes, J Fernández-Ruiz, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1991
The nature and severity of disabilities in long-stay psychiatric in-patients in South GlamorganI G Pryce, R D Griffiths, R M Gentry, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1993
How important is the assessment of social skills in current long-stay in-patients? An evaluation of clinical response to needs for assessment, treatment, and care in a long-stay psychiatric in-patient populationI G Pryce, R D Griffiths, R M Gentry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2001
Endocannabinoids control spasticity in a multiple sclerosis modelD Baker, G Pryce, J L Croxford, et al.
Brain : a Journal of Neurology|June 24, 2008
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosisJ M Anderson, D W Hampton, R Patani, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical and Experimental Immunology|July 17, 2020
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseasesD Baker, C A K Roberts, G Pryce, et al.
Clinical and Experimental Immunology|June 1, 1986
Characterization of monoclonal antibodies directed towards the microsomal/microvillar thyroid autoantigen recognized by Hashimoto autoantibodiesJ P Banga, R Mirakian, L Hammond, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2013
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitorsG Pryce, A Cabranes, J Fernández-Ruiz, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1991
The nature and severity of disabilities in long-stay psychiatric in-patients in South GlamorganI G Pryce, R D Griffiths, R M Gentry, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1993
How important is the assessment of social skills in current long-stay in-patients? An evaluation of clinical response to needs for assessment, treatment, and care in a long-stay psychiatric in-patient populationI G Pryce, R D Griffiths, R M Gentry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2001
Endocannabinoids control spasticity in a multiple sclerosis modelD Baker, G Pryce, J L Croxford, et al.
Brain : a Journal of Neurology|June 24, 2008
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosisJ M Anderson, D W Hampton, R Patani, et al.
Pageof 6